Hematopoietic stem cell activity (HSC activity)

Hematopoietic stem cell (HSC) activity refers to the complex biological process through which specialized stem cells in the bone marrow maintain the blood system via self-renewal and differentiation into all mature blood lineages. This activity is strictly regulated by the bone marrow niche through various signaling pathways, including Notch, Wnt, and TGF-beta, as well as cytokine signaling via receptors like c-Kit and CXCR4 [3, 14, 15]. While not a single molecular target itself, the modulation of HSC activity is a cornerstone of regenerative medicine and hematology, particularly in the context of stem cell transplantation, bone marrow recovery following chemotherapy, and the treatment of hematologic malignancies [2, 13]. Recent research also highlights its role in extra-hematologic conditions, such as the regulation of inflammatory cell production following myocardial infarction [1, 6]. Clinically, drugs like Filgrastim and Plerixafor are used to manipulate this activity by promoting the mobilization of HSCs from the bone marrow into the peripheral blood for collection and subsequent therapeutic use [8, 11].

Other names

HematopoiesisHSC functionBone marrow hematopoietic activityHSC self-renewal and differentiation

This entry refers to a biological process rather than a single molecular target. Therapeutic modulation is achieved through diverse mechanisms, including agonism of growth factor receptors (e.g., G-CSFR, TPO-R) to stimulate production, antagonism of chemokine receptors (e.g., CXCR4) to induce mobilization, or modulation of signaling pathways (e.g., Retinoic acid, TNF, or TGF-beta) to regulate quiescence and inflammatory response [1, 3, 11].